Related Experiment Video
Updated: Jun 11, 2026
03:07
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
Instituting a robot-assisted surgery programme at a tertiary care cancer centre
Nefertiti C duPont1, Khurshid A Guru, George B Iskander
1Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. nefertiti.dupont@roswellpark.org
Summary
Robot-assisted surgery is safe for gynecological oncology patients. Establishing a robotic program in a cancer center is feasible, with low complication rates.
Area of Science:
- Gynecological Oncology
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Describes the initial implementation of a robotic surgery program within a gynecological oncology service.
- Focuses on a tertiary care cancer center setting.
Purpose of the Study:
- To evaluate the perioperative outcomes of robot-assisted surgery in gynecological oncology patients.
- To assess the feasibility of establishing a robotic program in a tertiary care cancer center.
Main Methods:
- Retrospective study of 76 patients who were offered robot-assisted surgery.
- Analysis of perioperative outcomes, including complication rates and length of stay.
Main Results:
- 73 out of 76 patients underwent robot-assisted surgery; 3 required conversion to laparotomy.
- Common procedures included endometrial cancer treatment (51%), ovarian cancer risk reduction (18%), and uterine leiomyomata (8%).
- Median BMI was 30, with low median estimated blood loss (150 ml), operative time (195 min), and length of stay (1 day). Major and minor complication rates were 6.8% and 15.1%, respectively.
Conclusions:
- Robot-assisted surgery is a safe and appropriate option for gynecological patients.
- A gynecological oncology robotic program can be successfully established in a tertiary care cancer center.
